p300/MDM2 Complexes Participate in MDM2-Mediated p53 Degradation

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

High-Efficiency Transformation of Mammalian Cells by Plasmid DNA

Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113

The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases

Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952

Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain

Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346

Mutational Analysis of p53 in Human Tumors: Immunocytochemistry

Slade, N., & Moll, U. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-408-5:231 · Cited by 20

Nucleolar p14ARF Overexpression in Reed-Sternberg Cells in Hodgkin's Lymphoma

García, J. F., Villuendas, R., Sánchez‐Beato, M., Sánchez‐Aguilera, A., Sánchez, L., Priéto, I., & Piris, M. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64876-6 · Cited by 20

Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene

Chaudhry, S., Freebern, W. J., Smith, J. L., Butscher, W. G., Haggerty, C. M., & Gardner, K. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6767 · Cited by 20

Altered expression ofBRCA1,BRCA2, and a newly identifiedBRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines

Rauh‐Adelmann, C., Lau, K., Sabeti, N., Long, J. P., Mok, S. C., & Ho, S. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200008)28:4 · Cited by 48

Studies on modulation of the activity of tumor suppressor protein p53

Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 19

p19ARFDetermines the Balance between Normal Cell Proliferation Rate and Apoptosis during Mammary Gland Development

Yi, Y., Shepard, A., Kittrell, F. S., Mulac‐Jeričević, B., Medina, D., & Said, T. K. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0785 · Cited by 18

Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells

Nakamura, S., Roth, J. A., & Mukhopadhyay, T. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205343 · Cited by 18

MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer

Portman, N., Chen, J., & Lim, E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.777867 · Cited by 17

Control of apoptosis by SMAR 1

Malik, M. Z., Alam, M. J., Ishrat, R., Agarwal, S. M., & Singh, R. K. B. (2016) · Molecular BioSystems · doi:10.1039/c6mb00525j · Cited by 17

Mutation at Ser392 specifically sensitizes mutant p53H175 to mdm2-mediated degradation

Gillotin, S., Yap, D., & Lü, X. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11253 · Cited by 17

The Acetylase Activity of p300 Is Dispensable for MDM2 Stabilization

Zeng, S. X., Jin, Y., Kuninger, D., Rotwein, P. S., & Lu, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209030200 · Cited by 17

Impact of supraphysiologic MDM2 expression on chromatin networks and therapeutic responses in sarcoma

Bevill, S. M., Casaní-Galdón, S., Farran, C. E. E., Cytrynbaum, E. G., Macias, K. A., Oldeman, S. E., Oliveira, K. J., Moore, M. M., Hegazi, E., Adriaens, C., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100321 · Cited by 17

A newly identified Pirh2 substrate SCYL1‐BP1 can bind to MDM2 and accelerate MDM2 self‐ubiquitination

Yan, J. Y., Zhang, D., Di, Y., Shi, H., Rao, H., & Huo, K. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.027 · Cited by 16

Discrimination of single amino acid mutations of the p53 protein by means of deterministic singularities of recurrence quantification analysis

Porrello, A., Soddu, S., Zbilut, J. P., Crescenzi, M., & Giuliani, A. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20075 · Cited by 16

Aberrant Forms of Histone Acetyltransferases in Human Disease

van Beekum, O., & Kalkhoven, E. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_11 · Cited by 16

p53-Independent Down-Regulation of Mdm2 in Human Cancer Cells Treated with Adriamycin

Ma, Y., Yuan, R., Meng, Q., Goldberg, I. D., Rosen, E. M., & Fan, S. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0201 · Cited by 16

Structural assessment of single amino acid mutations: application to TP53 function

Yip, Y. L., Zoete, V., Scheib, H., & Michielin, O. A. (2006) · Human Mutation · doi:10.1002/humu.20379 · Cited by 16

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction

Clegg, H. V., Itahana, Y., Itahana, K., Ramalingam, S., & Zhang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038212 · Cited by 15

Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?

Oduah, E., & Grossman, S. R. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1702403 · Cited by 16

The Dynamics of Stress p53-Mdm2 Network Regulated by p300 and HDAC1

Arora, A., Gera, S., Maheshwari, T., Raghav, D., Alam, M. J., Singh, R. K. B., & Agarwal, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052736 · Cited by 15

Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma.

Akil, A., Ezzikouri, S., Feydi, A. E. E., Benazzouz, M., Afifi, R., Diagne, A., Benjouad, A., Dejean, A., Pineau, P., & Benjelloun, S. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.05.011 · Cited by 17

A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.

Lin, J., Jin, X., Page, C., Sondak, V. K., Jiang, G., & Reynolds, R. K. (2000) · PubMed · Cited by 15

Disrupting the p53-mdm2 interaction as a potential therapeutic modality

Moll, U. M., & Zaika, A. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0160 · Cited by 15

p53 controls neuronal death in the CA3 region of the newborn mouse hippocampus

Murase, S., Poser, S., Joseph, J., & McKay, R. D. G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07758.x · Cited by 14

HER-2/Neu signaling and therapeutic approaches in breast cancer

Zhou, B. P., Li, Y., & Hung, M. (2002) · Breast Disease · doi:10.3233/bd-2002-15103 · Cited by 14

The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53

Gillotin, S., & Lü, X. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.012 · Cited by 13

HSP27 role in cardioprotection by modulating chemotherapeutic doxorubicin-induced cell death

Ramani, S., & Park, S. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02048-4 · Cited by 13

Transcription factor sox‐2 inhibits co‐activator stimulated transcription

Bernadt, C. T., Nowling, T. K., & Rizzino, A. (2004) · Molecular Reproduction and Development · doi:10.1002/mrd.20168 · Cited by 13

CBP/p300, a promising therapeutic target for prostate cancer

Xu, H., Hou, Y., Zhao, Z., Zhang, J., Li, P., Cao, Y., Nie, X., & Hou, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07053-6 · Cited by 13

Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways

Yang, P., Liu, Q., Shen, H., Lin, J., Xu, X., Ji, Z., Han, X., & Shang, D. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s88779 · Cited by 10

Suppression of E1A-Mediated Transformation by the p50E4F Transcription Factor

Fernandes, E. R., & Rooney, R. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4739 · Cited by 10

Nuclear Accumulations of p53 and Mdm2 are Accompanied by Reductions in c-Abl and p300 in Zinc-Depleted Human Hepatoblastoma Cells

Alshatwi, A. A., Han, T., Schoene, N. W., & Lei, K. Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100516 · Cited by 10

Knockout of onecut2 inhibits proliferation and promotes apoptosis of tumor cells through SKP2-mediated p53 acetylation in hepatocellular carcinoma

Li, C., Xiao, Y., Zhou, J., Liu, S., Zhang, L., Song, X., Guo, X., Song, Q., Zhao, J., & Deng, N. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05518-3 · Cited by 9

Transcription coactivator CBP has direct DNA binding activity and stimulates transcription factor DNA binding through small domains

Song, C.-Z., Keller, K. L., Chen, Y., Murata, K., & Stamatoyannopoulos, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00842-2 · Cited by 9

A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population

Reza, H. A., Anamika, W. J., Chowdhury, M. M. K., Mostafa, M., & Uddin, M. A. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.125 · Cited by 11

Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability

Doleželová, P., Cetkovská, K., Vousden, K. H., & Uldrijan, S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.034 · Cited by 9

Adenovirus Infection of Primary Malignant Lymphoid Cells

STRAIR, R. K., Sheay, W., Goodell, L. A., White, E., Rabson, A. B., & Medina, D. J. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190210187 · Cited by 9

Activation et modifications post-traductionnelles de p53 après dommage de l’ADN

Leblanc, V., & May, P. (2002) · médecine/sciences · doi:10.1051/medsci/2002185577 · Cited by 13

p53 Localization

Maki, C. G. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_8 · Cited by 10

Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX

Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 9

Cited2 is a key regulator of placental development and plasticity

Kuna, M., & Soares, M. J. (2024) · BioEssays · doi:10.1002/bies.202300118 · Cited by 7

Exploring the Mechanisms, Biomarkers, and Therapeutic Targets of TRIM Family in Gastrointestinal Cancer

Weng, C., Jin, R., Jin, X., Yang, Z., He, C., Zhang, Q., Xu, J., & Lv, B. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s482340 · Cited by 7

SCYL1BP1 has Tumor-suppressive Functions in Human Lung Squamous Carcinoma Cells by Regulating Degradation of MDM2

Yang, Z.-P., Yong-hong, X., Ling, D.-Y., Li, J.-R., Jiang, J. F., Fan, Y., Zheng, J.-L., & Wu, W. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.17.7467 · Cited by 8

Regulation of expression of the p21CIP1 gene by the transcription factor ZNF217 and MDM2

Mantsou, A., Koutsogiannouli, E. A., Haitoglou, C., Papavassiliou, A. G., & Papanikolaou, N. A. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0026 · Cited by 7

p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX

Levy, R., Gregory, E., Borcherds, W. M., & Daughdrill, G. W. (2019) · Biomolecules · doi:10.3390/biom9030083 · Cited by 7

p53 Tumor Suppressor: Functional Regulation and Role in Gene Therapy

Farooq, Z., Wani, S., Ragunathrao, V. A. B., Kochhar, R. K., & Anwar, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105029 · Cited by 7

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors

Maietta, I., Peschio, F. D., Buonocore, P., Viscusi, E., Laudati, S., Iannaci, G., Minopoli, M., Motti, M. L., & Falco, V. D. (2022) · Cancers · doi:10.3390/cancers15010121 · Cited by 6

p53 N-terminal binding and stabilisation by PIAS3 inhibits MDM2-induced p53 ubiquitination and regulates cell growth

Zhao, Z., Wu, L., Shi, H., & Wu, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1993 · Cited by 6

Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53

Wang, Q., Yang, Y., Wang, L., Zhang, P., & Yu, L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.038 · Cited by 5

Tumor Growth Suppression by the Coactivator p300

Suganuma, T., & Ikeda, M. (2008) · Journal of Oral Biosciences · doi:10.1016/s1349-0079(08)80025-4 · Cited by 5

p53 Tumor Suppressor Protein

Ashcroft, M. A., & Vousden, K. H. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_7 · Cited by 5

PP2A adapter protein IER5 induces dephosphorylation and degradation of MDM2, thereby stabilizing p53

Nakada, T., Koga, M., Takeuchi, H., Doi, K., Sugiyama, H., & Sakurai, H. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111739 · Cited by 5

MDM2: RING Finger Protein and Regulator of p53

Wu, L., & Maki, C. G. (2005) · Springer eBooks · doi:10.1007/0-387-27421-9_34 · Cited by 4

Characteristic Mutational Damages in Gastric and Colorectal Adenocarcinomas

Yermekova, S., Orazgaliyeva, M., Goncharova, T., Rakhimbekova, F., Kaidarova, D. R., & Shatkovskaya, O. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.11.3939 · Cited by 4

Structure and functions of transcriptional coactivators p300/CBP and their roles in regulation of interleukin gene expression

Shao, Y. (2004) · Chinese Science Bulletin · doi:10.1360/982004-349 · Cited by 4

Trans‐regulated Silencing and Reactivation of TP53 Tumor Suppressor Gene in Malignant Transformation and Its Reversion

Yang, L., & Sasaki, M. S. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00893.x · Cited by 4

The Role of Epigenetics in Cervical Cancer

Alfaro‐Mora, Y., Herrera, L. A., Cáceres-Gutiérrez, R. E., Andonegui-Elguera, M. A., Domínguez-Gómez, G., & Díaz‐Chávez, J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89819 · Cited by 4

A dynamical model of apoptosis and its role in tumor progression

Laise, P., Fanelli, D., & Arcangeli, A. (2011) · Communications in Nonlinear Science and Numerical Simulation · doi:10.1016/j.cnsns.2011.09.014 · Cited by 3

Mathematical Modeling of Linear Docking. I. Determination of Regions of Binding of Protein Molecules

Kulikov, K. G., & Koshlan, T. (2018) · Technical Physics · doi:10.1134/s1063784218080108 · Cited by 3

A Narrative Review of the TP53 and Its Product the p53 Protein

Foroutan, B. (2023) · OBM Genetics · doi:10.21926/obm.genet.2302185 · Cited by 8

Atomistic Insights Into the Regulatory Mechanisms Mediated by Post- Translational Modifications: Molecular Dynamics Investigations

Papaleo, E., Casiraghi, N. A., Arrigoni, A., & Ranzani, V. (2012) · Current Physical Chemistry · doi:10.2174/1877946811202040344 · Cited by 3

Electronic Polarization at the Interface between the p53 Transactivation Domain and Two Binding Partners

Corrigan, A., & Lemkul, J. A. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c02268 · Cited by 2

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors

Maietta, I., Peschio, F. D., Buonocore, P., Viscusi, E., Laudati, S., Iannaci, G., Minopoli, M., Motti, M. L., & Falco, V. D. (2023) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pacr3ed.3.23.3 · Cited by 2

The Effect of PEI-Mediated E1A on the Radiosensitivity of Hepatic Carcinoma Cells

Xu, D., Yao, J., Zhang, Y., Xiao, N., Peng, P., Li, Z., Pan, Z., & Yao, Z. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.4.911 · Cited by 2

STK38 is a PPARγ-interacting protein promoting adipogenesis

Qian, K., Yu, D., Wang, W., Jiang, M., Yang, R., Brown, R., & Gong, D. (2021) · Adipocyte · doi:10.1080/21623945.2021.1980257 · Cited by 2

Adenovirus inhibition of immune-mediated apoptosis

Wold, W. S. M., Tóth, K., Doronin, K., Kuppuswamy, M. N., Lichtenstein, D. L., & Tollefson, A. E. (1999) · Clinical Immunology Newsletter · doi:10.1016/s0197-1859(00)80039-4 · Cited by 2

Set the Tone:

(2018) · Yale University Press eBooks · doi:10.2307/j.ctvqc6gvg.12 · Cited by 2

EP300 (E1A binding protein p300)

Huret, J. L. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/37578 · Cited by 1

Adhesion-Mediated Signalling in Cancer: Recent Advances and Mathematical Modelling

Crociani, O., Becchetti, A., Fanelli, D., & Arcangeli, A. (2014) · Biophysical Reviews and Letters · doi:10.1142/s1793048014300047 · Cited by 1

Cell death induction in p53-Mdm2 network regulated by p300 and HDAC1 using pinning control

Suárez, O. J., Vega, C. J., Sanchez, E. N., & Santiago, A. E. G. (2019) · International Conference on Electrical Engineering, Computing Science and Automatic Control (CCE) · doi:10.1109/iceee.2019.8884509 · Cited by 1

A Novel Transcriptional Repression Domain Mediates p21 WAF1/CIP1 Induction of p300 Transactivation

(2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5360a-5360a.2000 · Cited by 1

Adenovirus early region I proteins: Action through interaction

Roger, J. (2001) · Perspectives in medical virology · doi:10.1016/s0168-7069(01)05003-0 · Cited by 1

UV Response of Mammalian p53 Tumor Supressor Gene

Mälkönen, T. (1999) · Työväentutkimus Vuosikirja · Cited by 1

Oxygen-dependent Regulation of Transcription by the Hypoxia-inducible Factor-1

Ruas, J. L. (2005) · Figshare · Cited by 1

Avaliação in vitro da expressão das proteínas PTEN, Akt, Mdm2 e p53 em células de carcinoma epidermóide de cabeça e pescoço submetidas a ação de EGF e 17-AAG

Paulo, S. (2007) · Cited by 1

Mdm2 and ARF

Klotzbücher, A., & Kubbutat, M. H. G. (2002) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-59259-153-4_10 · Cited by 1

Mutant p53 binds RNA to drive mitochondrial dysfunctionPreprint

Zhou, W., Long, A., Douglas, C. J., Gallegos, D., Burke, J. M., MacMillan, D. W. C., Hacisuleyman, E., & Seath, C. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.12.688127 · Cited by 1

Regulation of the p53 Response by Cellular Growth and Survival Factors

Brown, L. M., & Benchimol, S. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_5 · Cited by 1

Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation

Latonen, L. (2003) · Työväentutkimus Vuosikirja

The role of PIM1 in cell survival

Gu, J. J. (2009) · doi:10.7273/000005647

Transferência gênica de p19Arf e interferon-b em células de melanoma.

Ribeiro, A. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2011.tde-10022012-143841

THE ROLE OF P53 IN OXIDATIVE STRESS AND POLYGLUTAMINE NEUROTOXICITY

Dunn, J. C. (2003) · UKnowledge (University of Kentucky)

E2F1 induction following DNA damage and oncogene activation

Helgason, G. V. (2007) · Enlighten: Theses (The University of Glasgow)

Novel functions of the MOZ double PHD finger domain

Deeves, S. E. (2012) · Nottingham ePrints (University of Nottingham)

Regulation of FOXO stability and activity by MDM2 E3 ligase

Fu, W. (2007) · Digital Commons - University of South Florida (University of South Florida)

A Structural Model for the P53 Complex with DNA Response Elements: Implications for P53 Function and Future Research Directions

Harrington, R. E., Zhurkin, V. B., Durell, S. R., Jernigan, R. L., Nagaich, A. K., & Appella, E. (2000) · Springer eBooks · doi:10.1007/978-3-642-59631-5_19

Avaliação in vitro da expressão das proteínas PTEN, Akt, Mdm2 e p53 em células de carcinoma epidermóide de cabeça e pescoço submetidas a ação de EGF e 17-AAG

Pontes, F. S. C. (2007) · doi:10.11606/t.23.2007.tde-02012008-151120

p53 and DNA damage checkpoint responses in the human prostate

af Hällström, T. (2007)

MECHANISMS OF POLYGLUTAMINE EXPANDED HUNTINGTIN INDUCED TOXICITY

Jiang, H. (2003) · D-Scholarship@Pitt (University of Pittsburgh)

유비퀴틴화에 의한 세포 내 p53의 기능 조절

정진혁, 이준영, 이선미, 최태부, & 안성관 (2009) · KSBB Journal

Increased Radioresistance and Accelerated B Cell LymphomasinMicewithMdmxMutationsthatPrevent

Wang, Y. V., Leblanc, M., Wade, M. R., Jochemsen, A. G., & Wahl, G. M. (2009)

Molecular Mechanisms Underlying the Oncogenic Function of SS18 and SSX

D’Arcy, P. (2008) · Figshare

A regulatory network of Mdm2 and members of the Polycomb Group (PcG) family

Wienken, M. M. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5475

The Regulation of G Protein-Coupled Receptor (GPCR) Signal Transduction by p90 Ribosomal S6 Kinase 2 (RSK2)

Sheffler, D. J. (2006) · OhioLink ETD Center (Ohio Library and Information Network)

p53 Tumor Suppressor Opens Gateways for Cancer Therapy

Dai, M., Gallegos, J. R., & Lu, H. (2008) · CRC Press eBooks · doi:10.1201/9780849387999.ch48

The Role of PIK3CA in Cisplatin Resistance of Cervical Cancer

Merry, C. D. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28345

Towards the Investigation of the Effects of Nitration on the Activity of the Human p53 Tumour Suppressor Protein. Nitration of the p53 Tumour Suppressor Protein

Husaini, R. (2014) · Bradford Scholars (University of Bradford)

Understanding p53 structure and targeting mutant p53 for improved cancer therapy

Zhang, Q. (2018) · Figshare

p16 and ARF: Crossroads of Tumorigenesis

Yarbrough, W. G., & Xiong, Y. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00185-4

References

(2009) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420078930.bmatt

Mdm2 Mutant Defective in Binding p300 Promotes Ubiquitination but Not Degradation of p53

Zhu, Q., Yao, J., Wani, G., Wani, M. A., & Wani, A. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102634200 · Cited by 57

Analysis of the degradation function of Mdm2.

Kubbutat, M. H. G., Ludwig, R., Levine, A. J., & Vousden, K. H. (1999) · PubMed · Cited by 102

Dual Role of p300 in the Regulation of p53 Stability

Kawai, H., Nie, L., Wiederschain, D., & Yuan, Z.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107770200 · Cited by 35

Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

Grossman, S. R., Deato, M. D. E., Brignone, C., Chan, H. M., Kung, A. L., Tagami, H., Nakatani, Y., & Livingston, D. M. (2003) · Science · doi:10.1126/science.1080386 · Cited by 454

The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2

Dunzendorfer-Matt, T., Martinez‐Yamout, M. A., Dyson, H. J., & Wright, P. E. (2004) · Biochemical Journal · doi:10.1042/bj20040564 · Cited by 42